Engineered Un1Cas12f1 with boosted gene-editing activity and expanded genomic coverage
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2501292122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Li Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences and Oceanography, Shenzhen University, Shenzhen 518060, China. Hauptthemen laut MEDLINE: Gene Editing. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Nation Key Research and Development Program of China, National Natural Science Foundation of China, Department of Science and Technology of Guangdong Province.
Abstract (Originalsprache)
Compact programmable nucleases provide versatile genome editing tools with therapeutic potential, particularly when delivered via adeno-associated virus (AAV) vectors. However, their limited editing efficacy and stringent protospaceradjacent motif (PAM) requirements impose significant limitations in practical application. Here, we engineered MiniCasUltra, an optimized Un1Cas12f1 variant, through rational mutagenesis. MiniCasUltra exhibits sixfold higher editing activity than Un1Cas12f1, minimal off-target effects (on/off-target ratio > 10), and an expanded PAM preference (5′-WBTR). Using a single AAV vector encoding MiniCasUltra and two single-guide RNAs, we achieved simultaneous editing of two disease-causing genes ( Pten and Fah ) in mouse liver, with indel rates of 15.82% and 29.39%, respectively- significantly surpassing CasMINI V3.1 (3.45% and 10.98%). Furthermore, AAV delivery of MiniCasUltra targeting a noncanonical 5′-TCTG PAM site in human vascularendothelial growth factor A reduced choroidal neovascularization (CNV) lesions in a laser-induced CNV mouse model of neovascular age-related macular degeneration, a leading global cause of blindness. The broad and effective targeting capabilities of MiniCasUltra, coupled with its compact size, highlight its potential for in vivo genome editing and therapeutic interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Sciences and Oceanography, Shenzhen University, Shenzhen 518060, China.
- College of Physics and Optoelectronic Engineering, Shenzhen University, Shenzhen 518060, China.
- Department of Ophthalmology, Shanghai Eye, Ear, Nose and Throat Hospital, State Key Laboratory of Brain Function and Disorders, Fudan University, Shanghai 200031, China.
- State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai 200031, China.
- National Health Commission Key laboratory of Myopia and Related Eye Diseases, Shanghai 200031, China.
- Shanghai Key Laboratory of Rare Disease Gene Editing and Cell Therapy; Shanghai Engineering Research Center of Synthetic Immunology, Shanghai 200032, China.
Förderung
- Nation Key Research and Development Program of China
- National Natural Science Foundation of China
- Department of Science and Technology of Guangdong Province
- MOST | NSFC | National Science Fund for Distinguished Young Scholars (NSF for Distinguished Young Scholars)
- National Natural Science Fundation of China
- National Youth talent support program
- Shanghai Medical Innovation Research Program
- (the "Dawn" Program of) Shanghai Municipal Education Commission
Zitieren
APA
Chen, L., Zhou, X., Huang, C., Zhang, Y., Xin, C., Hong, J., & Wang, Y. (2025). Engineered Un1Cas12f1 with boosted gene-editing activity and expanded genomic coverage. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2501292122
Vancouver
Chen L, Zhou X, Huang C, Zhang Y, Xin C, Hong J, et al. Engineered Un1Cas12f1 with boosted gene-editing activity and expanded genomic coverage. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2501292122
BibTeX
@article{Chen2025,
author = {Chen, Li and Zhou, Xujiao and Huang, Chengsi and Zhang, Yirou and Xin, Changchang and Hong, Jiaxu and Wang, Yu},
title = {Engineered Un1Cas12f1 with boosted gene-editing activity and expanded genomic coverage},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2501292122}
}
EUVIMED